Humanized mice for Immuno-oncology

How Humanized Mouse Models Enforce Preclinical Studies in Immuno-OncologyПодробнее

Humanized M NSG PBMC and CD34+ Mouse Models 2023 | Applied StemCell, Inc.Подробнее

[Webinar] Human Immune Reconstituted Mice in Translational Medicine: Challenges and SolutionsПодробнее

Comparing Immunodeficient Models for Cancer, Immunity, and Transplant ResearchПодробнее

Humanized Mouse Model Options for Autoimmune DiseasesПодробнее

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse ModelsПодробнее

Novel Humanized Mouse Model for Assessment of Human Allogeneic Responses in Organ TransplantationПодробнее

Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T TherapiesПодробнее

How can Humanized Mouse Models be Used to Study Cancer and Develop Immune Targeted Therapies?Подробнее

[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 2nd)Подробнее

Fully humanized mouse models for Immuno-Oncology preclinical drug candidate selection [WEBINAR]Подробнее

Keynote: Carl June | Therapy Gladstone-UCSF Institute of Genomic Immunology SymposiumПодробнее

Human Immune System Reconstituted NCG Models For ImmunotherapyПодробнее

New Checkpoints and BiomarkersПодробнее

Immune-Humanized PDX Model-Estrogen-Independent, Hormone Receptor-Positive Metastatic Breast CancerПодробнее

Fully humanized mouse models for Immuno-Oncology preclinical drug candidate selectionПодробнее

Webinar: Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft PlatformsПодробнее

Improving Translational Medicine by Humanization of Mouse ModelsПодробнее

A Novel Clinically Relevant Graft-Versus-Leukemia Model in Humanized MiceПодробнее

Webinar: Introduction to In Vivo Platforms for Cancer ImmunotherapyПодробнее